Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
Sponsor: Novartis Pharmaceuticals
Metastatic Castration Resistant Prostate Cancer
Italy
Sponsor: Novartis Pharmaceuticals
Relapsing Remitting Multiple Sclerosis (RRMS)
Canada
Sponsor: Novartis Pharmaceuticals
Familial Hypercholesterolemia - Heterozygous
United States, Argentina, Austria, Belgium, Brazil +18 more
Sponsor: Novartis Pharmaceuticals
Heterozygous or Homozygous Familial Hypercholesterolemia
United States, Argentina, Brazil, Canada, Czechia +21 more
Sponsor: University Hospital, Bordeaux
Scleroderma, Localized · Scleroderma, Systemic
France
- Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast CancerActive Not Recruiting
Sponsor: SOLTI Breast Cancer Research Group
Breast Cancer Stage II
France, Portugal, Spain
Sponsor: University of Utah
Metastatic Pancreatic Carcinoma · Stage II Pancreatic Cancer · Stage IIA Pancreatic Cancer · Stage IIB Pancreatic Cancer
United States
- Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic DermatitisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Atopic Dermatitis
United States, Bulgaria, Canada, Czechia, France +4 more
- Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent GlioblastomaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Newly Diagnosed and Recurrent Glioblastoma
United States, France, Germany, Italy, Portugal +1 more
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus (SLE)
Argentina, Australia, China, Czechia, France +10 more
- Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis (MS)
United States, Argentina, Australia, Austria, Belgium +20 more
Sponsor: Ottawa Heart Institute Research Corporation
Heart Failure
Canada
- Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe ProteinuriaNot Yet Recruiting
Sponsor: Geisinger Clinic
Referral and Consultation · Glomerulonephritis · Hematuria · Proteinuria
United States
- Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast CancerActive Not Recruiting
Sponsor: Jonsson Comprehensive Cancer Center
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Anatomic Stage IIB Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
United States
Sponsor: Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
United States
Sponsor: Novartis Pharmaceuticals
Chagas Disease · Heart Failure
Argentina, Brazil, Colombia, Mexico
- Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBCActive Not Recruiting
Sponsor: Women's Cancer Study Group GmbH
Breast Cancer Female
Germany
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
- 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)Recruiting
Sponsor: Melissa Lumish
Liver Cancer · Hepatocellular Carcinoma · Metastatic Liver Cancer
United States
Sponsor: M.D. Anderson Cancer Center
Metastatic Castration Resistant Prostate Cancer · Cytopenia · Anemia · Thrombocytopenia
Sponsor: Novartis Pharmaceuticals
Prostate Cancer
Japan
Sponsor: Novartis Pharmaceuticals
Acute Myeloid Leukemia
United States, Hong Kong, Hungary, Israel, Italy +2 more
Sponsor: Novartis Pharmaceuticals
Uncomplicated Plasmodium Falciparum Malaria
Burkina Faso, Côte d’Ivoire, Gabon, Mali, Republic of the Congo
Sponsor: University of Kansas Medical Center
FSHD
United States, Brazil, Canada, United Kingdom
Sponsor: Novartis Pharmaceuticals
Uncomplicated Plasmodium Falciparum Malaria
Côte d’Ivoire, Gabon, Kenya